GHK-Cu (injectable form)

Published · Researched 2026-09-21

Overview

GHK-Cu is the copper(II) complex of the tripeptide glycyl-histidyl-lysine (GHK), first isolated from human plasma by Dr. Loren Pickart in 1973. Unlike the other compounds in this category it is naturally occurring — plasma levels fall by more than half after age 60 — and it has a long history in topical/cosmetic use. In 2026 the community splits into two camps: topical/cosmetic (creams, serums, microneedling — with actual clinical/cosmetic data) and injectable (subcutaneous, community-protocol, no human trials). This file covers the injectable form per the category assignment; the topical/injectable split is a defining feature of its discourse.

Social standing

Threads: Solid signal, expectation-management themed. @allthingsjrenee (2026-08-31, 57 likes): two weeks into injectable GHK-Cu and impatient, asking for a pep talk — emblematic of the "slow build" reputation. @francescruzph (2026-08-10, 86 likes): asking injectable users when they saw results and what they noticed; high curiosity with ambiguous outcomes.

Instagram: Looksmaxxing and biohacking communities are the loudest venue. MuscleChemistry forum roundups quote a widely-shared user review calling it "probably my favorite peptide," claiming scar/stretch-mark reduction, wrinkle improvement, and hair regrowth including bald spots. Tressless community threads (hair-loss forum, 2026) show injectable GHK-Cu stacked with minoxidil/finasteride with mixed-to-positive hair-density reports.

Facebook: GHK-Cu appears inside FB Group healing-stack discussions (GLOW = BPC-157 + TB-500 + GHK-Cu) more than as a standalone topic; it is the third wheel of the triple healing stack rather than a headline compound.

Looksmax.org (second layer): A long, detailed thread on injectable use surfaces the main complaint pattern — injection-site pain reported more consistently than benefits, and a well-sourced poster argues the copper complex's poor solubility profile may explain both the pain and inconsistent results; some users advocate GHK (copper-free) as an alternative. Low-health-literacy noise is present (joke/troll dosing replies).

Main praise: skin quality and hair density improvements; scar/stretch-mark fading; pairs well cosmetically with BPC-157/TB-500. Main complaints: slow and ambiguous results ("no one seems to be reaping its benefits" per one detailed skeptic post); injection-site pain/stinging; copper-toxicity worries; topical-vs-injectable evidence gap — topical has clinical data, injectable is community protocol only.

Social validation

Tier 1. Strong evidence on all three primary platforms: Threads (high-engagement injectable-experience posts), Instagram (owner content — looksmax/hair-loss communities with before/after discussion), Facebook (FB Group stack discussions). Reddit/forum layer (Tressless, MuscleChemistry, looksmax.org) adds depth.

Key specs table

Property Value
Sequence Gly-His-Lys (GHK) + Cu²⁺ complex (copper tripeptide-1)
Molecular weight 403.9 g/mol (GHK-Cu complex); 340.38 g/mol is the copper-free GHK — vendors sometimes quote the wrong figure
Molecular formula C₁₄H₂₄CuN₆O₄
CAS 49557-75-7
Typical vial size sold 50 mg (most common); 100 mg also common
Half-life UNVERIFIED — no human PK data for the injectable route
Solubility Water-soluble; blue-green lyophilized powder (blue tint = copper complex, a visual authenticity cue per vendors)
Storage −20°C long-term; refrigerated after reconstitution (vendor guidance; UNVERIFIED independently)
Purity claims ≥99% HPLC (vendor-claimed; verify against batch COA)

Pricing

Observation date: 2026-09-20. GHK-Cu street prices (50 mg vial unless noted):

Typical per-mg: roughly $0.58–$1.30/mg — the cheapest compound in this category by far. FB Marketplace used range: N/A — no resale market observed.

What's included / what's needed

Lyophilized blue-green powder in a sealed vial (OptimaSciences bundles 5 mL bacteriostatic water; most vendors do not). NOT included unless stated: bacteriostatic water, syringes, alcohol swabs. Topical users additionally source cosmetic vehicles/serums separately.

Support reality

Testing culture is the same Janoshik-COA standard; Eon Peptides adds QR-code vial authentication tied to batch COAs, and Kylo Peptides uses ISO/IEC 17025-accredited labs with published per-lot COAs. Money-back guarantees exist at the premium end (Eon: refund plus paid retest if HPLC comes back under 99%). The distinctive support issue for GHK-Cu is the topical/injectable split: vendors sell one product used two ways, and no vendor can point to human safety data for the injectable route — community cycling protocols (e.g. 8 weeks on/off) are folk harm-reduction, not clinical guidance. Injection-pain complaints are widespread enough to be a vendor-selection factor.

Community verdict

GHK-Cu is the cosmetic darling of the healing category — hair and skin anecdotes are abundant and it anchors the GLOW triple stack — but injectable use is the least evidence-backed application of the five compounds here. Community sentiment splits between believers citing visible skin/hair change and skeptics noting the benefits never quite materialize; everyone agrees the topical form is the one with real data behind it.

Regulatory & safety status

RESEARCH CHEMICAL — NOT FDA/EMA APPROVED for human use (injectable). Topical GHK-Cu is a long-established cosmetic ingredient; the injectable form has no approved human indication, no human clinical trials, and no long-term safety data. Athlete note: not explicitly named on the WADA Prohibited List, but as a non-approved substance it falls under WADA's S0 catch-all for athletes. Sold legally only as research material labeled "not for human or veterinary use." Community-reported tolerability is generally described as good aside from injection-site pain/redness; copper-toxicity concerns are raised but no community-verified cases surfaced — mark long-term injectable safety UNVERIFIED.

Photos

6 distinct real photographs, verified and converted to JPEG. No photo is reused across views or items.

  • Views present: hero, rear, top, detail, in-use, box (ghk-cu-hero.jpg, ghk-cu-rear.jpg, ghk-cu-top.jpg, ghk-cu-detail.jpg, ghk-cu-in-use.jpg, ghk-cu-box.jpg).
  • Missing views: side, scale — no real photos of these views found; named honestly rather than substituted.
  • Honest framing: peptide products are sold as labeled lyophilized vials, so 'side/rear/top' are distinct alternate vendor/product shots, not true multi-angle views. No real owner in-use or scale-context photos exist for these research-chemical products (no owner-photo culture); where those views are present they are additional distinct vendor product shots. One candidate photo with a synthetic molecule-graphic background was rejected.

Not medical advice. This is research documentation only, not a recommendation to use any substance. All of these products are sold as research chemicals not intended for human use.

GHK-Cu (injectable form) — box view
box view Original vendor page URL not recorded in research dossier
GHK-Cu (injectable form) — detail view
detail view Original vendor page URL not recorded in research dossier
GHK-Cu (injectable form) — hero view
hero view Original vendor page URL not recorded in research dossier
GHK-Cu (injectable form) — in-use view
in-use view Original vendor page URL not recorded in research dossier
GHK-Cu (injectable form) — rear view
rear view Original vendor page URL not recorded in research dossier
GHK-Cu (injectable form) — top view
top view Original vendor page URL not recorded in research dossier

Sources